Autosomal dominant dopa-responsive parkinsonism in a multigenerational Swiss family

Parkinsonism Relat Disord. 2008 Aug;14(6):465-70. doi: 10.1016/j.parkreldis.2007.11.013. Epub 2008 Mar 14.

Abstract

Aim: To describe a large family with autosomal dominant parkinsonism.

Background: Seven genes are directly implicated in autosomally inherited parkinsonism. However, there are several multigenerational large families known with no identifiable mutation.

Material and methods: Family members were evaluated clinically, by history and chart review. Genetic investigation included SCA2, SCA3, UCHL1, SNCA, LRRK2, PINK1, PRKN, PGRN, FMR1 premutation, and MAPT. The proband underwent brain fluorodopa PET (FD-PET) scan, and one autopsy was available.

Results: Eleven patients had a diagnosis of Parkinson's disease (PD), nine women. Mean age of onset was 52 with tremor-predominant dopa-responsive parkinsonism. Disease progression was slow but severe motor fluctuations occurred. One patient required subthalamic nucleus deep-brain stimulation with a good motor outcome. One patient had mental retardation, schizophrenia and became demented, and another patient was demented. Three patients and also two unaffected subjects had mild learning difficulties. All genetic tests yielded negative results. FD-PET showed marked asymmetric striatal tracer uptake deficiency, consistent with PD. Pathological examination demonstrated no Lewy bodies and immunostaining was negative for alpha-synuclein.

Conclusion: Apart from a younger age of onset and a female predominance, the phenotype was indistinguishable from sporadic tremor-predominant PD, including FD-PET scan results. As known genetic causes of autosomal dominant PD were excluded, this family harbors a novel genetic defect.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antiparkinson Agents / therapeutic use*
  • Brain / diagnostic imaging
  • Chromosome Disorders / diagnostic imaging
  • Chromosome Disorders / drug therapy*
  • Chromosome Disorders / genetics*
  • DNA Mutational Analysis
  • Dihydroxyphenylalanine / analogs & derivatives
  • Female
  • Genes, Dominant
  • Humans
  • Levodopa / therapeutic use*
  • Male
  • Middle Aged
  • Mutation / physiology
  • Parkinson Disease / diagnostic imaging
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / genetics*
  • Pedigree
  • Phenotype
  • Positron-Emission Tomography
  • Radiopharmaceuticals

Substances

  • Antiparkinson Agents
  • Radiopharmaceuticals
  • fluorodopa F 18
  • Levodopa
  • Dihydroxyphenylalanine